Morgan Lewis advised Replimune Group on the deal.Replimune Group Inc. announced its approximately $260 million public offering of 6,810,658 shares of common stock, inclusive of the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
